PSMA-PET Webinar Series
Invicro’s PSMA-PET webinar series features industry-leading KOL’s who discuss the role imaging biomarkers play in the discovery and development of life-changing drugs for prostate cancer.
PSMA is a popular target for both imaging to identify the presence of prostate cancer and to deliver drugs directly to the cancerous cells. A PSMA-PET scan is a powerful molecular imaging technique that can accurately localize prostate cancer and assess tumors’ level of PSMA expression.
Learn more by downloading our webinar series below.
- 3,000+ Research Trials Managed
- 450+ Clinical Trials Managed
- ~40,000,000 (DICOM) Images Processed
- 800+ Molecules Labeled
CNS Webinar Series
Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.Watch Now
Oncology Webinar Series
Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.Watch Now